ESR1 and breast cancer: HER2-positive tumors are divided into two subtypes: luminal B HER2-positive subtype with positive expression of ER, PR, and HER2 (triple positive BC) and HER2-enriched subtype with negative expression of ER and/or PR and positive expression of HER2.